Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells

Human Gene Therapy

Volumn 18, Issue 8, 2007, Pages 701-711

  Goding, Stephen R ^a,b   Yang, Qin ^a,b   Knudsen, Kristina B ^c   Potter, Douglas M ^b,d   Basse, Per H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MACROGOL;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENE THERAPY; CANCER IMMUNOTHERAPY; CD25+ T LYMPHOCYTE; CELL BASED GENE THERAPY; CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; IMMUNOMODULATION; LOW DRUG DOSE; LUNG METASTASIS; LUNG TUMOR; MOUSE; NATURAL KILLER CELL; NONHUMAN;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENETIC VECTORS; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; NEOPLASMS; TRANSDUCTION, GENETIC;

ANIMALIA; MUS;

EID: 34548477012     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.052     Document Type: Article

References (35)

1. BASSE, P., and GOLDFARB, R.H. (1994). Localization of immune effector cells to tumor metastases. Immunol. Ser. 61, 149-158.
2. BASSE, P., HERBERMAN, R.B., NANNMARK, U., JOHANSSON, B.R., HOKLAND, M., WASSERMAN, K., and GOLDFARB, R.H. (1991). Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J. Exp. Med. 174, 479-488.
3. BASSE, P.H., GOLDFARB, R.H., HERBERMAN, R.B., and HOKLAND, M.E. (1994). Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. In Vivo 8, 17-24.
4. CARSON, W.E., YU, H., DIERKSHEIDE, J., PFEFFER, K., BOUCHARD, P., CLARK, R., DURBIN, J., BALDWIN, A.S., PESCHON, J., JOHNSON, P.R., KU, G., BAUMANN, H., and CALIGIURI, M.A. (1999). A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J. Immunol. 162, 4943-4951.
5. CARSON, W.E., DIERKSHEIDE, J.E., JABBOUR, S., ANGHELINA, M., BOUCHARD, P., KU, G., YU, H., BAUMANN, H., SHAH, M.H., COOPER, M.A., DURBIN, J., and CALIGIURI, M.A. (2000). Coadministration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: Critical role of natural killer cell interferon-γ production and STAT-mediated signal transduction. Blood 96, 1465-1473.
6. GATELY, M.K., DESAI, B.B., WOLITZKY, A.G., QUINN, P.M., DWYER, C.M., PODLASKI, F.J., FAMILLETTI, P.C., SINIGAGLIA, F., CHIZONNITE, R., GUBLER, U., and STERN, A.S. (1991). Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147, 874-882.
7. GODING, S., YANG, Q., MI, Z., ROBBINS, P.D., and BASSE, P.H. (2007). Targeting of products of genes to tumor sites using adoptively transferred A-NK and T-LAK cells. Cancer Gene Ther. 14, 441-450.
8. GRAHAM, F.L., and VAN DER EB, A.J. (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467.
9. HALIN, C., GAFNER, V., VILLANI, M.E., BORSI, L., BERNDT, A., KOSMEHL, H., ZARDI, L., and NERI, D. (2003). Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor α. Cancer Res. 63, 3202-3210.
10. JEWETT, A., and BONAVIDA, B. (1993). Pivotal role of endogenous TNF-α in the IL-2-driven activation and proliferation of the functionally immature NK free subset. Cell Immunol. 151, 257-269.
11. JIMENEZ, M., KAMEYAMA, K., MALOY, W.L., TOMITA, Y., and HEARING, V.J. (1988). Mammalian tyrosinase: Biosynthesis, processing, and modulation by melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U.S.A. 85, 3830-3834.
12. JIMENEZ, M., MALOY, W.L., and HEARING, V.J. (1989). Specific identification of an authentic clone for mammalian tyrosinase. J. Biol. Chem. 264, 3397-3403.
13. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
14. KOBAYASHI, T., URABE, K., ORLOW, S.J., HIGASHI, K., IMOKAWA, G., KWON, B.S., POTTERF, B., and HEARING, V.J. (1994). The Pmel 17/silver locus protein: Characterization and investigation of its melanogenic function. J. Biol. Chem. 269, 29198-29205.
15. LAUWERYS, B.R., GAROT, N., RENAULD, J.C., and HOUSSIAU, F.A. (2000). Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J. Immunol. 165, 1847-1853.
16. LJUNGGREN, H.G., and KARRE, K. (1990). In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
17. MANETTI, R., PARRONCHI, P., GIUDIZI, M.G., PICCINNI, M.P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
18. MANETTI, R., GEROSA, F., GIUDIZI, M.G., BIAGIOTTI, R., PARRONCHI, P., PICCINNI, M.P., SAMPOGNARO, S., MAGGI, E., ROMAGNANI, S., and TRINCHIERI, G. (1994). Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179, 1273-1283.
19. MITTEREDER, N., MARCH, K.L., and TRAPNELL, B.C. (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70, 7498-7509.
20. NISHIOKA, Y., HIRAO, M., ROBBINS, P.D., LOTZE, M.T., and TAHARA, H. (1999). Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res. 59, 4035-4041.
21. ORTALDO, J.R., MASON, A.T., GERARD, J.P., HENDERSON, L.E., FARRAR, W., HOPKINS, R.F., III, HERBERMAN, R.B., and RABIN, H. (1984). Effects of natural and recombinant IL 2 on regulation of IFN γ production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J. Immunol. 133, 779-783.
22. PAPPO, I., TAHARA, H., ROBBINS, P.D., GATELY, M.K., WOLF, S.F., BARNEA, A., and LOTZE, M.T. (1995). Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy. J. Surg. Res. 58, 218-226.
23. + T lymphocytes, and NK cells. J. Immunol. 149, 3495-3502.
24. RABINOWICH, H., HERBERMAN, R.B., and WHITESIDE, T.L. (1993). Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell Immunol. 152, 481-498.
25. ROSENBERG, S.A., LOTZE, M.T., and MULE, J.J. (1988). NIH conference: New approaches to the immunotherapy of cancer using interleukin-2. Ann. Intern. Med. 108, 853-864.
26. SAMARAWEERA, P., DONATIEN, P.D., QAZI, S., KOBAYASHI, T., HEARING, V.J., PANTHIER, J.J., and ORLOW, S.J. (1999). Identification and characterization of a melanocyte-specific novel 65-kDa peripheral membrane protein. Eur. J. Biochem. 266, 924-934.
27. SATOH, Y., ESCHE, C., GAMBOTTO, A., SHURIN, G.V., YURKOVETSKY, Z.R., ROBBINS, P.D., WATKINS, S.C., TODO, S., HERBERMAN, R.B., LOTZE, M.T., and SHURIN, M.R. (2002). Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. J. Exp. Ther. Oncol. 2, 337-349.
28. SIEGEL, J.P., and PURI, R.K. (1991). Interleukin-2 toxicity. J. Clin. Oncol. 9, 694-704.
29. SMYTH, M.J., THIA, K.Y., CRETNEY, E., KELLY, J.M., SNOOK, M.B., FORBES, C.A., and SCALZO, A.A. (1999). Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162, 6658-6662.
30. SON, Y.I., DALLAL, R.M., MAILLIARD, R.B., EGAWA, S., JONAK, Z.L., and LOTZE, M.T. (2001). Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-γ production, and expansion of natural killer cells. Cancer Res. 61, 884-888.
31. VALENZUELA, J., SCHMIDT, C., and MESCHER, M. (2002). The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 169, 6842-6849.
32. YANG, Q., HOKLAND, M.E., BRYANT, J.L., ZHANG, Y., NANNMARK, U., WATKINS, S.C., GOLDFARB, R.H., HERBERMAN, R.B., and BASSE, P.H. (2003). Tumor-localization by adoptively transferred, interleukin-2-activated NK cells leads to destruction of well-established lung metastases. Int. J. Cancer 105, 512-519.
33. YANG, Q., GODING, S., HAGENAARS, M., CARLOS, T., ALBERTSSON, P., KUPPEN, P., NANNMARK, U., HOKLAND, M.E., and BASSE, P.H. (2005). Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells. Cancer Immunol. Immunother. 55, 699-707.
34. YE, W., YOUNG, J.D., and LIU, C.C. (1996). Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes. Cell Immunol. 174, 54-62.
35. YEH, P., and PERRICAUDET, M. (1997). Advances in adenoviral vectors: From genetic engineering to their biology. FASEB J. 11, 615-623.